Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2021-01-20
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fibromyalgia and Olive Oil
NCT04245592
Effects of Photobiomodulation in a Population Suffering From Fibromyalgia
NCT04248972
Effect of a Vegan Mediterranean Diet on Cardiometabolic Biomarkers, Functional Capacity, and Quality of Life in Patients with Fibromyalgia
NCT06804460
Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia
NCT00830167
Neurodynamic Intervention in Fibromyalgia
NCT01826695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Group 1: consisting of 20 patients diagnosed with FM, who received a daily dose of 3 capsules (2 in the morning and 1 in the evening) of Mygrium® during 60 days.
Olive Polyphenols
Patients with fibromyalgia of Group 1 will consume Olive Polyphenols daily during 60 days.
Group 2
Group 2: 20 patients diagnosed with FM, who received a daily dose of 3 capsules (2 in the morning and 1 in the evening) of a placebo (maltodextrins) during 60 days. This intervention group served as a control.
Placebo
Patients with fibromyalgia of Group 2 will consume a placebo daily during 60 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Olive Polyphenols
Patients with fibromyalgia of Group 1 will consume Olive Polyphenols daily during 60 days.
Placebo
Patients with fibromyalgia of Group 2 will consume a placebo daily during 60 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with grade II obesity (body mass index ≥ 35 kg/m2).
* Active smokers.
* Pregnancy.
* Regular treatment with acetylsalicylic acid, estrogen, corticosteroids, antioxidants or lipid-lowering drugs.
* Participation in another research study.
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Solvitae Medical, S.L
UNKNOWN
University of Jaén
OTHER
Universidad de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ALMA RUS MARTÍNEZ
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mª Luisa del Moral, MD
Role: PRINCIPAL_INVESTIGATOR
University of Jaén
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Jaén
Jaén, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
de la Cruz Cazorla S, Blanco S, Rus A, Molina-Ortega FJ, Ocana E, Hernandez R, Visioli F, Moral MLD. Nutraceutical Supplementation as a Potential Non-Drug Treatment for Fibromyalgia: Effects on Lipid Profile, Oxidative Status, and Quality of Life. Int J Mol Sci. 2024 Sep 14;25(18):9935. doi: 10.3390/ijms25189935.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Polyphenol-Fibromyalgia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.